Drug & medication recalls Moderate risk

Phenazopyridine Hydrochloride Tablets recalled over manufacturing violations

Recall date
October 24, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Burel Pharmaceuticals Inc recalls Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Burel Pharmaceuticals…
Recall number
D-0161-2017
FDA classification
Class II
Brand / firm
Burel Pharmaceuticals Inc
Sold / distributed
Nationwide

Why it was recalled

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Burel Pharmaceuticals, Inc., Richland, MS --- NDC 35573-304-10

Get recall alerts

Free email alert whenever Burel Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Burel Pharmaceuticals Inc